ActiveGRANT
DoW Breast Cancer, Breakthrough Award Level 4
Department of DefenseDept. of the Army -- USAMRAA
AI Overview
DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.
This summary is AI-generated from the official solicitation.
Key Details
Agency
Department of Defense
Funding Amount
—
Release Date
May 4, 2026
Due Date
September 30, 2026
Official Description
<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism con...
View on official sourceChange History
Opportunity AddedMay 4, 2026 at 4:44 PM
DoW Breast Cancer, Breakthrough Award Level 4
New Grants.gov opportunity: DoW Breast Cancer, Breakthrough Award Level 4
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial